THE EFFECT OF FENCLOFENAC ON THYROID FUNCTION

A. Kurtz,S. Capper,J. Clifford,M. Humphrey,L. Lukinac
DOI: https://doi.org/10.1111/j.1365-2265.1981.tb00645.x
1981-08-01
Clinical Endocrinology
Abstract:The non‐steroidal anti‐inflammatory agent fenclofenac competitively inhibits the binding of thyroxine (T4) and triiodothyronine (T3) by thyroxine‐binding globulin (TBG). Eight male volunteers completed a 4‐week study during which they took fenclofenac 600 mg twice daily. The concentration of fenclofenac in serum reached a plateau after 1 week of therapy after which the mean concentration (± SEM) of the drug in serum was 78–6 ± 6–2 mg/l. During the steady state period on treatment there were reductions of the mean serum concentrations of total T4 to 35% (P < 0·001), total T3 to 55% (P < 0·001), free T4 to 69% (P < 0·001) and free T3 to 90% (NS) of the respective pretreatment values.
What problem does this paper attempt to address?